Results
|
2021.
|
|
|
2022.
|
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. [electronic resource] by
- LeWitt, Peter A
- Rezai, Ali R
- Leehey, Maureen A
- Ojemann, Steven G
- Flaherty, Alice W
- Eskandar, Emad N
- Kostyk, Sandra K
- Thomas, Karen
- Sarkar, Atom
- Siddiqui, Mustafa S
- Tatter, Stephen B
- Schwalb, Jason M
- Poston, Kathleen L
- Henderson, Jaimie M
- Kurlan, Roger M
- Richard, Irene H
- Van Meter, Lori
- Sapan, Christine V
- During, Matthew J
- Kaplitt, Michael G
- Feigin, Andrew
Producer: 20110615
In:
The Lancet. Neurology vol. 10
Availability: No items available.
|
|
2023.
|
|
|
2024.
|
|
|
2025.
|
|
|
2026.
|
|
|
2027.
|
Dopamine replacement therapy and deep brain stimulation of the subthalamic nuclei induce modulation of emotional processes at different spatial frequencies in Parkinson's disease. [electronic resource] by
- Mermillod, Martial
- Mondillon, Laurie
- Rieu, Isabelle
- Devaux, Damien
- Chambres, Patrick
- Auxiette, Catherine
- Dalens, Hélène
- Coulangeon, Louise Marie
- Jalenques, Isabelle
- Durif, Franck
Producer: 20141014
In:
Journal of Parkinson's disease vol. 4
Availability: No items available.
|
|
2028.
|
|
|
2029.
|
|
|
2030.
|
|
|
2031.
|
|
|
2032.
|
|
|
2033.
|
|
|
2034.
|
|
|
2035.
|
|
|
2036.
|
|
|
2037.
|
|
|
2038.
|
|
|
2039.
|
|
|
2040.
|
|